{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:02:48Z","timestamp":1794528168307,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":38,"publisher":"Springer New York","isbn-type":[{"value":"9781493940097","type":"print"},{"value":"9781493940110","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-4011-0_16","type":"book-chapter","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:40:51Z","timestamp":1472604051000},"page":"187-205","source":"Crossref","is-referenced-by-count":1,"title":["New Mouse Models to Investigate the Efficacy of Drug Combinations in Human Chronic Myeloid Leukemia"],"prefix":"10.1007","author":[{"given":"Hanyang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Woolfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09792","volume":"470","author":"ES Lander","year":"2011","unstructured":"Lander ES (2011) Initial impact of the sequencing of the human genome. Nature 470:187\u2013197","journal-title":"Nature"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7:118\u2013130","journal-title":"Nat Rev Immunol"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1182\/blood.V90.6.2168","volume":"90","author":"A Castellanos","year":"1997","unstructured":"Castellanos A, Pintado B, Weruaga E et al (1997) A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 90:2168\u20132174","journal-title":"Blood"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/MCB.9.7.2798","volume":"9","author":"IK Hariharan","year":"1989","unstructured":"Hariharan IK, Harris AW, Crawford M et al (1989) A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol 9:2798\u20132805","journal-title":"Mol Cell Biol"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/blood-2002-10-3182","volume":"102","author":"K Inokuchi","year":"2003","unstructured":"Inokuchi K, Dan K, Takatori M et al (2003) Myeloproliferative disease in transgenic mice expressing P230 Bcr\/Abl: longer disease latency, thrombocytosis, and mild leukocytosis. Blood 102:320\u2013323","journal-title":"Blood"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/344251a0","volume":"344","author":"N Heisterkamp","year":"1990","unstructured":"Heisterkamp N, Jenster G, ten Hoeve J et al (1990) Acute leukaemia in bcr\/abl transgenic mice. Nature 344:251\u2013253","journal-title":"Nature"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V91.6.2067","volume":"91","author":"H Honda","year":"1998","unstructured":"Honda H, Oda H, Suzuki T et al (1998) Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr\/abl: a novel transgenic model for human Ph1-positive leukemias. Blood 91:2067\u20132075","journal-title":"Blood"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","volume":"105","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, Gottgens B, Zhang P et al (2005) Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 105:324\u2013334","journal-title":"Blood"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/71691","volume":"24","author":"CS Huettner","year":"2000","unstructured":"Huettner CS, Zhang P, Van Etten RA et al (2000) Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 24:57\u201360","journal-title":"Nat Genet"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","volume":"21","author":"L Li","year":"2012","unstructured":"Li L, Wang L, Li L et al (2012) Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell 21:266\u2013281","journal-title":"Cancer Cell"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang B, Ho YW, Huang Q et al (2012) Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 21:577\u2013592","journal-title":"Cancer Cell"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20141661","volume":"212","author":"G Giotopoulos","year":"2015","unstructured":"Giotopoulos G, van der Weyden L, Osaki H et al (2015) A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression. J Exp Med 212:1551\u20131569","journal-title":"J Exp Med"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science 247:824\u2013830","journal-title":"Science"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/j.1460-2075.1990.tb08212.x","volume":"9","author":"AG Elefanty","year":"1990","unstructured":"Elefanty AG, Hariharan IK, Cory S (1990) bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J 9:1069\u20131078","journal-title":"EMBO J"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1073\/pnas.87.17.6649","volume":"87","author":"MA Kelliher","year":"1990","unstructured":"Kelliher MA, McLaughlin J, Witte ON et al (1990) Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR\/ABL. Proc Natl Acad Sci U S A 87:6649\u20136653","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1182\/blood-2002-05-1324","volume":"100","author":"X Jiang","year":"2002","unstructured":"Jiang X, Ng E, Yip C et al (2002) Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo. Blood 100:3731\u20133740","journal-title":"Blood"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2003-05-1550","volume":"102","author":"X Jiang","year":"2003","unstructured":"Jiang X, Stuible M, Chalandon Y et al (2003) Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. Blood 102:2976\u20132984","journal-title":"Blood"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S Li","year":"1999","unstructured":"Li S, Ilaria RL Jr, Million RP et al (1999) The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 189:1399\u20131412","journal-title":"J Exp Med"},{"key":"16_CR19","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L et al (1998) Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 92:3780\u20133792","journal-title":"Blood"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1084\/jem.20072316","volume":"205","author":"LL Zhou","year":"2008","unstructured":"Zhou LL, Zhao Y, Ringrose A et al (2008) AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem\/progenitor cells. J Exp Med 205:2657\u20132671","journal-title":"J Exp Med"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y Chen","year":"2009","unstructured":"Chen Y, Hu Y, Zhang H et al (2009) Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet 41:783\u2013792","journal-title":"Nat Genet"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","volume":"103","author":"Y Hu","year":"2006","unstructured":"Hu Y, Swerdlow S, Duffy TM et al (2006) Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph\u2009+\u2009leukemia in mice. Proc Natl Acad Sci U S A 103:16870\u201316875","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","volume":"94","author":"T Holyoake","year":"1999","unstructured":"Holyoake T, Jiang X, Eaves C et al (1999) Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94:2056\u20132064","journal-title":"Blood"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V91.7.2406","volume":"91","author":"JC Wang","year":"1998","unstructured":"Wang JC, Lapidot T, Cashman JD et al (1998) High level engraftment of NOD\/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 91:2406\u20132414","journal-title":"Blood"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood.V92.4.1390","volume":"92","author":"F Dazzi","year":"1998","unstructured":"Dazzi F, Capelli D, Hasserjian R et al (1998) The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic\/severe combined immunodeficiency mice reflect the phase of the donor\u2019s disease: an in vivo model of chronic myelogenous leukemia biology. Blood 92:1390\u20131396","journal-title":"Blood"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.leu.2403649","volume":"19","author":"W Eisterer","year":"2005","unstructured":"Eisterer W, Jiang X, Christ O et al (2005) Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia 19:435\u2013441","journal-title":"Leukemia"},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.V91.2.630","volume":"91","author":"ID Lewis","year":"1998","unstructured":"Lewis ID, McDiarmid LA, Samels LM et al (1998) Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD\/SCID mice using blood-derived mononuclear or CD34+ cells. Blood 91:630\u2013640","journal-title":"Blood"},{"key":"16_CR28","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood.V79.8.2089.2089","volume":"79","author":"CL Sawyers","year":"1992","unstructured":"Sawyers CL, Gishizky ML, Quan S et al (1992) Propagation of human blastic myeloid leukemias in the SCID mouse. Blood 79:2089\u20132098","journal-title":"Blood"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1073\/pnas.94.10.5320","volume":"94","author":"M Bhatia","year":"1997","unstructured":"Bhatia M, Wang JC, Kapp U et al (1997) Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 94:5320\u20135325","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.leu.2403650","volume":"19","author":"Y Chalandon","year":"2005","unstructured":"Chalandon Y, Jiang X, Christ O et al (2005) BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Leukemia 19:442\u2013448","journal-title":"Leukemia"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.leu.2403335","volume":"18","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Jiang X, Loutet S et al (2004) Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL. Leukemia 18:1006\u20131012","journal-title":"Leukemia"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2007-09-112573","volume":"111","author":"M Copland","year":"2008","unstructured":"Copland M, Pellicano F, Richmond L et al (2008) BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors. Blood 111:2843\u20132853","journal-title":"Blood"},{"key":"16_CR33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jnci\/djt006","volume":"105","author":"M Chen","year":"2013","unstructured":"Chen M, Gallipoli P, DeGeer D et al (2013) Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex. J Natl Cancer Inst 105:405\u2013423","journal-title":"J Natl Cancer Inst"},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.18632\/oncotarget.2353","volume":"5","author":"H Lin","year":"2014","unstructured":"Lin H, Chen M, Rothe K et al (2014) Selective JAK2\/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem\/progenitor cells. Oncotarget 5:8637\u20138650","journal-title":"Oncotarget"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.exphem.2013.07.001","volume":"41","author":"I Sloma","year":"2013","unstructured":"Sloma I, Beer PA, Saw KM et al (2013) Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia. Exp Hematol 41:837\u2013847","journal-title":"Exp Hematol"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1073\/pnas.0602646103","volume":"103","author":"F Zeng","year":"2006","unstructured":"Zeng F, Chen MJ, Baldwin DA et al (2006) Multiorgan engraftment and differentiation of human cord blood CD34+ Lin- cells in goats assessed by gene expression profiling. Proc Natl Acad Sci U S A 103:7801\u20137806","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/cr.2013.60","volume":"23","author":"F Zeng","year":"2013","unstructured":"Zeng F, Huang SZ, Gong ZJ et al (2013) Long-term deregulated human hematopoiesis in goats transplanted in utero with BCR-ABL-transduced lin(-)CD34(+) cord blood cells. Cell Res 23:859\u2013862","journal-title":"Cell Res"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K et al (2002) NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175\u20133182","journal-title":"Blood"}],"container-title":["Methods in Molecular Biology","Chronic Myeloid Leukemia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-4011-0_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:21:36Z","timestamp":1601040096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-4011-0_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493940097","9781493940110"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-4011-0_16","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-4011-0","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}